Inventor · disambiguated record
Magdolna Bodnar
Also filed as: BODNAR MAGDOLNA · BODNÁR MAGDOLNA
4 granted patents·8 pending applications·20 citations·filing 2005–2014
71Inventor score
Top patents by PatentIndex Score
12 records- 0178US7740883B2Nanoparticles from chitosanUNIV DEBRECEN·Filed 2005·Granted Jun 22, 2010·7 cites·14 claims
- 0277US7976825B2Cancer cell diagnosis by targeting delivery of nanodevicesBORBELY JANOS·Filed 2008·Granted Jul 12, 2011·8 cites·23 claims
- 0354US2008193547A1Polymeric nanoparticles by ion-ion InteractionsBORBELY JANOS·Filed 2007·Application pending·0 cites
- 0451US2008160096A1Polymeric nanoparticles by ion-ion interactionsBERBELY JANOS·Filed 2007·Application pending·0 cites
- 0548US7879818B2Hyaluronic acid-based cross-linked nanoparticlesBORBELY JANOS·Filed 2006·Granted Feb 1, 2011·5 cites·24 claims
- 0646US2013302243A1Radiolabeled nanosystem, process for the preparation thereof and its useBBS NANOMEDICINA ZRT·Filed 2013·Application pending·0 cites
- 0744US2013302255A1Novel targeted paramagnetic contrast agentBBS NANOMEDICINA ZRT·Filed 2013·Application pending·0 cites
- 0842US2014099266A1Magnetic fluid nanosystemBORBELY JANOS·Filed 2013·Application pending·0 cites
- 0938US2015004103A1Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agentBORBÉLY JÁNOS·Filed 2013·Application pending·0 cites
- 1038US2014294967A1Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing itBORBÉLY JÁNOS·Filed 2014·Application pending·0 cites
- 1138US2015004096A1Tumorspecific SPECT/MR(T1), SPECT/MR(T2) and SPECT/CT contrast agentsBORBÉLY JÁNOS·Filed 2013·Application pending·0 cites
- 1233US9352988B2Pb2+-ion binding by polyacid-based nanoparticlesBORBELY JANOS·Filed 2006·Granted May 31, 2016·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Magdolna Bodnar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →